Disciplines: Pharmacy
Additional Information
Western Schools 365 is valid only for the registered individual, and is non-transferable
No promotional discounts may be applied to the purchase of the Western Schools 365 Pharmacy Online Membership
Sign up for the Western Schools 365 Online Membership

Western Schools 365 Pharmacy Membership


Reg. Prices
Just $84.95
Item # YS900
New

With the Western Schools 365 Pharmacy Online Membership you get: 

  • Unlimited access to all our high-quality, evidence-based online CE courses for pharmacy professionals for a full year
  • Unlimited certificates for a full year
  • One price to fulfill some or all of your CE needs
  • The convenience of having all your online CE managed in one place
  • Instant access to certificates when courses are complete
  • When we publish New or Updated courses, they’ll automatically be added to your membership; retired courses will automatically be removed
  • Note: Western Schools 365 is valid only for the registered individual, and is non-transferable. Courses may be completed for credit only once during the one-year membership.

How it works:

  • Once you've purchased your membership, you'll be directed to your My Membership page, where you can select the courses you'd like to enroll in
  • Read your course, take the exam, print your certificate instantly. Everything is online, so it's easy to manage!
  • We'll remind you by email before your subscription expires so you have time to complete anything you still need to do

 

This product includes the following courses:
Click on the title to see more and read the course

Antidepressants, 2nd Edition

Price: $25.95 Hours:3 Contact Hours
Item # Y8000  

Start Date: September 16, 2016

Expiration Date: September 15, 2019

The purpose of this course is to provide current, evidence-based information for pharmacists (RPhs) on the mechanisms of action, pharmacokinetic and pharmacodynamics parameters, potential adverse events, adverse event management strategies, and special considerations affecting medication use and selection for medications used to treat depressive disorders. Although many medications used to treat depression have been around for several decades, new medications are constantly under development and it is important that healthcare professionals stay abreast of these new developments. In addition, the way that many of these medications with antidepressant properties are used in clinical practice continues to change. Although only some RPhs may specialize in mental health, all will encounter patients with mental health conditions such as major depressive disorder. This course is designed for RPhs practicing in all settings who may encounter patients taking antidepressants or be involved in initiating treatment with antidepressants.

Universal Activity Number (UAN) - 0607-0000-16-001-H01-P

Type of Activity - Knowledge

Topic Designator - 01– Disease State Management/Drug Therapy

Antiplatelet Therapy: Implications for Patient Management

Price: $32.95 Hours:4 Contact Hours
Item # Y8003  

Start Date: September 16, 2016

Expiration Date: September 16, 2019

Antiplatelet medications are commonly used in cardiovascular disorders and are among the most commonly utilized medications in the country. The drugs are sometimes used alone but other times are used in combination to achieve optimal benefits. With both intravenous and oral agents, the clinician must understand the interplay between intravenous and oral therapy and the nuances of dual therapy versus monotherapy. In addition, the clinician must understand the critical differences in pharmacologic and pharmacokinetic parameters of these agents to ensure selection of the one option that is superior to the others or appropriate patient monitoring.

This course is designed for clinicians who provide care to patients currently taking antiplatelet medications. The purpose of this course is to increase clinicians’ knowledge of antiplatelet medications so that they can identify the optimal therapy and safely utilize these medications.

The information in this course was current at the time of publication. Pharmacotherapy is rapidly changing, new pharmaceutical agents are continuously being developed and approved, and older agents are being investigated in new ways; therefore, the clinician should stay abreast of new medications and ongoing research findings and their implications in the delivery of patient care.

Universal Activity Number (UAN) - 0607-0000-16-011-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Anxiolytics and Traditional Mood Stabilizers

Price: $39.95 Hours:5 Contact Hours
Item # Y8011  

Start Date: September 16, 2016

Expiration Date: September 16, 2019

The care of patients with mental health diagnoses is by no means limited to psychiatric facilities or practices. Due to the prevalence of mental illness in the U.S. population, patients taking psychiatric medications are treated in virtually all healthcare settings. Anxiety disorders, as a group, represent the most common form of psychiatric illness, and in turn, anti-anxiety medications are prescribed and dispensed with great frequency. Therefore, it is imperative that pharmacists maintain current knowledge of these common psychiatric illnesses and treatments.

This course is designed for pharmacists in all settings. The purpose of this course is to provide an overview of the psychiatric pharmacotherapy of anxiety disorders and bipolar disorder. This course provides the learner with essential information on anxiolytic and mood stabilizer medications. Clinical pharmacology and pharmacokinetics are briefly discussed in order to explain the actions of the drugs, their effects on symptoms, their most common side effects, and their most serious adverse reactions. Interactions with other medications and potential for abuse of some drugs are also presented. Learners should be able to apply the material from this course to patient management and teaching scenarios.

Universal Activity Number (UAN) - 0607-0000-16-009-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Approaches to Geriatric Pharmacology for Pharmacists: A Primer

Price: $39.95 Hours:5 Contact Hours
Item # Y8002  

Start Date: September 16, 2016

Expiration Date: September 16, 2019

Geriatric patient care skills, once a specialty training area, have become a necessary skill for all healthcare providers. The elderly constitute a significant cohort among various care environments. Any problem, medication or otherwise, experienced by an older adult patient requires a multi-factorial assessment.

The topics covered in this course include core geriatric assessment principles that all disciplines caring for older adults are required to understand, geriatric pharmacological principles, and methods to assess appropriateness of medication use recommendations in the older adult. Individualization of care, a key concept in providing appropriate medication use in older adults, requires skills beyond the conventional assessment of adherence and efficacy. Core competencies include vigilant attention to the older adult’s risk of drug toxicity, appropriate application of adult clinical guidelines to older adults, risk versus benefit assessments, goals of therapy appropriate for older adults in alignment with patient preferences, and optimization of functional status.

This course is for the average to advanced-level pharmacy provider. It is a general primer providing a theoretical framework to help pharmacists apply the presented principles to overall medication management as well as to specialized therapeutic categories of medication use, such as cardiovascular, endocrinological, pulmonary, and psychotropic.

Universal Activity Number (UAN) - 0607-0000-16-010-H01-P

Type of Activity - Knowledge

Topic Designator - 01– Disease State Management/Drug Therapy

Cardiovascular Pharmacology, 3rd Edition

Price: $39.95 Hours:5 Contact Hours
Item # Y8031  

Release Date: January 5, 2017

Expiration Date: January 5, 2020

According to data from the Center for Disease Control, 610,000 people die from heart disease in the United States annually.  One in every four deaths is due to cardiovascular disease. There are also 12 million yearly visits to physician’s offices and close to 4 million hospital discharges for cardiovascular disease. Treatment of cardiovascular disease and monitoring for therapeutic efficacy and side effects of the drugs used require a sound knowledge of the pharmacology of these agents.

Ongoing education is needed to keep pace with these evolving changes and to equip pharmacists with the necessary knowledge and skills to implement the most recent advances in treatment. Pharmacists have an important responsibility in caring for patients who are receiving these medications. Knowledge of cardiovascular medications, their effects on the body, and their administration; assessment of therapeutic and adverse effects; and patient education are essential. The purpose of this course is to provide an overview of cardiovascular pharmacology. With an ever-increasing number of patients living longer, quality pharmacy care for those receiving drugs for cardiovascular disease will make this knowledge critical. 


Universal Activity Number (UAN) - 0607-0000-17-018-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Diabetes Management: Insulin Pharmacotherapy Options

Price: $19.95 Hours:2 Contact Hours
Item # Y8028  

Start Date: January 5, 2017

Expiration Date: January 5, 2020

Treatment guidelines for diabetes recommend a patient-centered approach to therapy beginning with lifestyle changes (diet, exercise, and weight loss). Both insulin and non-insulin pharmacotherapies are available to help decrease blood glucose levels, reduce the risk of short- and long-term complications, and improve the patient’s quality of life.

Many new pharmacotherapies have become available in recent years. The variety of options is ideal for patients with diabetes, but this vast array of choices may make treating diabetes daunting for health-care providers. In addition, new guidelines for the treatment of diabetes have been released by both the American Diabetes Association and the American Association of Clinical Endocrinologists. In order to effectively manage patients with diabetes, it is important to stay current with the standard of care for treatment of diabetes and the therapeutic options available. This course reviews the available insulin formulations and their role in treating type 1 and 2 diabetes.


Universal Activity Number (UAN) - 0607-0000-17-016-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Diabetes Management: Non-Insulin Pharmacotherapy Options

Price: $19.95 Hours:2 Contact Hours
Item # Y8029  

Start Date: January 5, 2017

Expiration Date: January 5, 2020

Diabetes is a chronic disease state with no known cure. For this reason, diabetes management is intended to prevent complications and improve the patient’s quality of life. As a result of its high incidence and economic burden, diabetes management is an area of tremendous research. Many new pharmacotherapies have become available in recent years. The variety of options is ideal for patients with diabetes, but this vast array of choices may make treating diabetes daunting for healthcare providers. In addition, new guidelines for the treatment of diabetes have been released by both the American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists (AACE). In order to effectively manage patients with diabetes, it is important to stay current with the standard of care for treatment of diabetes and the therapeutic options available. It is the aim of this course to review the current treatment guidelines for type 2 diabetes management and the pharmacotherapies available on the market today. Although insulin can be used to treat type 2 diabetes, the focus will remain on non-insulin therapies.


Universal Activity Number (UAN) - 0607-0000-17-017-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

This course is an extract of, and should not be taken in conjunction with, Y8006 - Diabetes Management: Pharmacotherapy Options for Diabetes Mellitus.

Diabetes Management: Pharmacotherapy Options for Diabetes Mellitus

Price: $25.95 Hours:3 Contact Hours
Item # Y8006  

Start Date: September 16, 2016

Expiration Date: September 15, 2019

Diabetes is a chronic disease state with no known cure. For this reason, diabetes management is intended to prevent complications and improve the patient’s quality of life. If diabetes is left untreated or is poorly managed, the patient’s disease may progress more rapidly or precipitate a hyperglycemic crisis, or the patient may experience treatment-related adverse events, such as hypoglycemia. As diabetes progresses, patients may develop diabetes complications or comorbid conditions, such as hypertension, hypercholesterolemia, cardiovascular disease, retinopathy, diabetic kidney disease, neuropathy, non-alcoholic fatty liver disease, gum disease, hearing loss, erectile dysfunction, and depression.

As a result of its high incidence and economic burden, diabetes management is an area of tremendous research. Many new pharmacotherapies have become available in recent years. The variety of options is ideal for patients with diabetes, but this vast array of choices may make treating diabetes daunting for healthcare providers. In addition, new guidelines for the treatment of diabetes have been released by both the American Diabetes Association and the American Association of Clinical Endocrinologists. In order to effectively manage patients with diabetes, it is important to stay current with the standard of care for treatment of diabetes and the therapeutic options available. It is the aim of this course to review the current treatment guidelines for diabetes management and the pharmacotherapies, both new and time-tested, available on the market today.

Universal Activity Number (UAN) - 0607-0000-16-004-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Differentiating Antipsychotics: An Overview of Properties Impacting Drug Selection

Price: $32.95 Hours:4 Contact Hours
Item # Y8009  

Start Date: September 16, 2016

Expiration Date: September 15, 2019

New antipsychotic agents are constantly under development, and the ways in which antipsychotic medications are used in clinical practice continue to change. As new information becomes available, there are new indications, safety warnings, monitoring recommendations, and dosage formulations. It is important that healthcare providers stay abreast of these new developments to optimize treatment. Due to the high rate of refractory schizophrenia, it is especially important for healthcare providers to be knowledgeable about new treatment options to offer to patients for whom previous treatments have failed and educate patients about potential benefits and adverse events. In addition, many antipsychotics have labeled indications for treatment of other mental illnesses, such as major depressive disorder and bipolar disorder, as well as many off-label uses.

The purpose of this course is to provide current, evidence-based information on the mechanisms of action, pharmacokinetic and pharmacodynamic parameters, adverse events, adverse event management strategies, clinical indications, and special considerations regarding antipsychotic use. This course is designed for pharmacists practicing in all settings who may encounter patients taking antipsychotic medications or be involved in initiating and/or monitoring treatment with antipsychotics.

Universal Activity Number (UAN) - 0607-0000-16-007-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Echinacea and Garlic Supplementation: Uses, Effectiveness, and Safety

Price: $19.95 Hours:2 Contact Hours
Item # Y8027  

Start Date: August 9, 2017

Expiration Date: August 9, 2020

Echinacea was the number one dietary supplement in the U.S. according to the 2002 National Health Interview Survey (Barnes et al., 2004). Identifying the specific chemical principles within the three species of the perennial plant Echinacea that produce clinically relevant effects is the subject of ongoing research, and lack of this information hampers the ability to develop dosage forms and regimens that produce reliable clinical effects.  In the 2012 NHIS survey of dietary supplement use, garlic was ranked as the 8th most commonly used dietary supplement in the U.S. (Clarke et al., 2015). Garlic, a top ten dietary supplement, has a long history as a medicinal agent with anti-infective, anti-tumor, cardiovascular, and performance enhancing effects.  Many uses have been proposed for Echinacea and garlic.  Consumers have difficulty evaluating the literature and making appropriate choices with regard to the uses, dosing, adverse effects, interactions, and product quality of these supplements.  Pharmacists who are knowledgeable about Echinacea and garlic supplements can assist patients in the appropriate use of these products to achieve better health.


Universal Activity Number (UAN) - 0607-0000-17-024-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Fish Oil and Omega-3 Fatty Acid Supplementation: Uses, Effectiveness, and Safety

Price: $25.95 Hours:3 Contact Hours
Item # Y8014  

Start Date: November 23, 2016

Expiration Date: November 23, 2019

In 21st century health care, increased emphasis focuses on wellness and disease prevention, a central theme of integrative care. Integrative health care encompasses conventional and nontraditional health approaches in a coordinated way. All healthcare professionals should have an understanding of integrative health, its elements, and those products and practices that have been shown to be effective therapeutic measures. More than 30% of U.S. adults and about 12% of children report use of healthcare approaches developed outside of conventional, or Western, medicine in the most recent comprehensive survey on the use of nonmainstream health approaches in the United States. These measures can be “complementary” or “alternative” in nature.
 
Fish oil is currently the number one dietary supplement used by adults and children in the United States. According to the 2012 NHIS, nearly 8% of adults and approximately 1% of children had taken fish oil within the previous 30 days before completing the survey. Many uses have been proposed for fish oil supplements. Consumers have difficulty evaluating the literature and making appropriate choices with regard to the uses, dosing, adverse effects, interactions, and product quality. Health professionals who are knowledgeable about omega-3 fatty acid supplements can assist patients in the appropriate use of these products to achieve better health.

Universal Activity Number (UAN) -  0607-0000-16-015-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Ginkgo Supplementation: Uses, Effectiveness, and Safety

Price: $19.95 Hours:2 Contact Hours
Item # Y8025  

Release Date: August 28, 2017

Expiration Date: August 28, 2020

Gingko biloba is an herbal product obtained from a long-lived tree that has been cultivated and used as a therapeutic agent in Asia for centuries. The active principles are thought to be flavonoids and terpenoids that have antioxidant, vasodilating, and antiplatelet activity. Many indications have been proposed for Gingko biloba, but none has received strong evidence-based support to date; among the most-studied indications are cognition and dementia. Consumers have difficulty evaluating the literature and making appropriate choices with regard to the uses, dosing, adverse effects, interactions, and product quality of gingko. Pharmacists who are knowledgeable about ginkgo supplements can assist patients in the appropriate use of these products to achieve better health.


Universal Activity Number (UAN) - 0607-0000-17-025-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Ginseng Supplementation: Uses, Effectiveness, and Safety

Price: $19.95 Hours:2 Contact Hours
Item # Y8024  

Start Date: September 7, 2017

Expiration Date: September 7, 2020

The popular herb Ginseng is valued as a general tonic and for the ability to help the body cope with stress. There are two primary types of ginseng: Asian ginseng, also called Panax, Chinese, or Korean ginseng, and American ginseng. The active principles in ginseng are the ginsenosides. The quantity and type of ginsenoside differs between the types of ginseng, explaining the different properties of Asian versus American ginseng. Asian ginseng is classified as possibly effective for the following conditions: Alzheimer’s disease, chronic pulmonary disease, cognitive function, erectile dysfunction, premature ejaculation, sexual arousal in women, influenza, and multiple sclerosis–related fatigue. American ginseng is classified as possibly effective for diabetes and respiratory tract infections.This course helps pharmacists assisting patients in the appropriate use, dosing, adverse effects, interactions, and product quality of ginseng.


Universal Activity Number (UAN) - 0607-0000-17-026-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Glucosamine, Chondroitin, Melatonin, Coenzyme Q10, and Cranberry Supplementation: Uses, Effectiveness, and Safety

Price: $19.95 Hours:2 Contact Hours
Item # Y8026  

Start Date: July 27, 2017

Expiration Date: July 27, 2020

The dietary supplements discussed in this course are among the most popular in the United States, according to the 2012 National Health Interview Survey (Clarke, Black, Stussman, Barnes, & Nahin, 2015). The combination of glucosamine and chondroitin was the second most popular dietary supplement choice for consumers. Glucosamine salts and chondroitin, individually and in combination, have been investigated extensively for prevention and treatment of osteoarthritis pain and disease progression. Results have been mixed, with the combination of glucosamine sulfate and chondroitin sulfate showing the most positive results. Some studies show equal effectiveness of this combination and NSAID therapy. After completing this course, the learner will be able to identify and monitor potential drug interactions.

Coenzyme Q10 was number four in 2012, a big increase from 2007, when coenzyme Q10 was not in the top 10 supplements list. Cranberry was the seventh most popular supplement in 2012, staying in approximately the same place among the top 10 supplements.

Melatonin moved into the top 10 dietary supplements in 2012. It was ranked at number four behind fish oil, glucosamine/chondroitin, and probiotics. Melatonin is an endogenous hormone that regulates sleep. It can be used by exogenous administration for a number of circadian rhythm disorders, including treatment of blind patients, DSPS, and sleep-wake cycle disturbances. The learner will be able to understand its advantages and potential drug interactions.

Each of these supplements will be discussed individually and the course will provide the criteria for the effectiveness ratings used for the dietary supplements.


Universal Activity Number (UAN) - 0607-0000-17-002-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Introduction to Dietary Supplements and Alternative Practices

Price: $25.95 Hours:3 Contact Hours
Item # Y8023  

Start Date: May 8, 2017

Expiration Date: May 8, 2020

The evolution of integrative care has changed the way patients are focused on improving their health and wellness. It is essential that pharmacists have an understanding of integrative health and those products and practices that have been shown to be effective therapeutic measures. Complementary alternative medicine includes the natural products used to supplement the diet defined by the Food and Drug Administration as Dietary Supplements as well as alternative health systems and mind-body practices. Pharmacists need to have evidence-based contemporary knowledge about complementary therapies to advise patients who seek them for a variety of health conditions.


Universal Activity Number (UAN) - 0607-0000-17-019-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Managing Obesity as a Chronic Disease State

Price: $25.95 Hours:3 Contact Hours
Item # Y8001  

Start Date: September 16, 2016

Expiration Date: September 15, 2019

Obesity is a currently a glaring public health concern because of its severe physiologic and economic implications. It has been reported that the healthcare burdens associated with obesity can be attenuated through weight loss. Moderate weight loss has been reported to improve cardiovascular health and reduce the incidence of type 2 diabetes mellitus. With this in mind, in 2013, the American Medical Association officially classified obesity as a disease, and the American Heart Association, American College of Cardiology, and The Obesity Society released new guidelines that recommend using a multifactorial approach in the treatment of obesity, with comprehensive lifestyle modification as the foundation for weight loss, and using adjunctive antiobesity pharmacotherapy and/or bariatric surgery when appropriate.

Although several antiobesity drugs are now available, they remain underutilized. This may be attributed to safety concerns, perceptions of limited efficacy, and a general unwillingness of patients and prescribers to view obesity as a disease. Cost is another barrier to widespread use; these agents are available only as brand name products and can be costly. Furthermore, many health insurers do not cover these agents. It is the purpose of this course to familiarize pharmacists with the current options for the management of obesity in adults, with an emphasis on pharmacotherapy, so that they may better educate other healthcare providers and patients about their selection, uses, and potential adverse effects.

Universal Activity Number (UAN) - 0607-0000-16-002-H01-P

Type of Activity - Knowledge

Topic Designator - 01– Disease State Management/Drug Therapy

Oral Anticoagulant Therapy: Implications for Patient Management

Price: $32.95 Hours:4 Contact Hours
Item # Y8005  

Start Date: September 16, 2016

Expiration Date: September 16, 2019

Oral anticoagulants are indicated for the management of thrombotic conditions, namely, in the prevention of stroke and systemic embolization and in the treatment of venous thromboembolism. Within the past 6 years, the landscape of managing these conditions in the United States has changed dramatically.

The uptake of novel oral anticoagulants in clinical practice has been successful, although there are important drug and patient characteristics to consider when selecting among these therapies. This course is designed for pharmacists who are involved in decision making for oral anticoagulant selection or who take care of patients who have already been prescribed oral anticoagulants. The purpose of this course is to increase pharmacists’ knowledge of oral anticoagulants so that they can identify patients in whom therapy is indicated, assist in selecting the most appropriate option, and monitor and counsel the patient.

The focus of this course is on the newest oral anticoagulant drug therapies, their indications, and data supporting their use in clinical practice. Although warfarin has many uses outside of these focused indications, it will not be discussed within this course. This course begins with an overview of hemostasis and the process of thrombus formation. Next, risk assessment for thrombosis and bleeding is reviewed in the setting of atrial fibrillation and venous thromboembolism. An overview of the oral anti-coagulant prescribing information and key clinical trials follows. Finally, pearls for patient selection, monitoring, and counseling are provided.

Universal Activity Number (UAN) - 0607-0000-16-012-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

Pain Management Essentials

Price: $12.95 Hours:1 Contact Hour
Item # Y8035  

Start Date: June 14, 2017

Expiration Date: June 14, 2020

Challenges identified among healthcare providers, including pharmacists, are professional knowledge gaps on effective treatment for pain and practicing in professional silos when managing patients who suffer from pain. Collaboration among healthcare providers, interprofessional continuing education, and improved patient communication and empowerment are needed to manage pain appropriately. Furthermore, pharmacists have a meaningful and growing opportunity to ensure patients are managed appropriately in many states—balancing pain management and potential abuse—as they will always encounter those with pain, whether or not it is the patient’s primary issue.


Michigan Pharmacists - This course fulfills your pain management requirement.


Universal Activity Number (UAN) - 0607-0000-17-022-H04-P

Type of Activity - Knowledge

Topic Designator - 04 – General Pharmacy

Pain Management Therapies: Pharmacological and Nonpharmacological Modalities

Price: $39.95 Hours:5 Contact Hours
Item # Y8013  

Start Date: September 30, 2016

Expiration Date: September 30, 2019

Pain affects more than 100 million people in the United States. To address the multifactorial aspects of pain, a multimodal approach—using nonpharmacological, pharmacological, and supportive care modalities to manage different types of pain—has been the recommendation according to the most recent guidelines.

Challenges identified among healthcare providers, including pharmacists, are professional knowledge gaps on effective treatment for pain and practicing in professional silos when managing patients who suffer from pain. Collaboration among healthcare providers, interprofessional continuing education, and improved patient communication and empowerment are needed to manage pain appropriately. Furthermore, pharmacists have a meaningful and growing opportunity to ensure patients are managed appropriately—balancing pain management and abuse—as they will always encounter those with pain, whether or not it is the patient’s primary issue.

The purpose of this course is to provide evidenced-based information of nonpharmacological and pharmacological therapies for appropriate pain management using a multimodal approach. This course is designed for pharmacists practicing in any setting to be able to recommend different modalities to manage those suffering from different types of pain.

Universal Activity Number (UAN) - 0607-0000-16-013-H04-P

Type of Activity - Knowledge

Topic Designator - 04 – General Pharmacy

Parenteral Anticoagulant Therapy: Implications for Patient Management

Price: $25.95 Hours:3 Contact Hours
Item # Y8010  

Start Date: September 16, 2016

Expiration Date: September 16, 2019

Anticoagulants are central to the management of cardiovascular and thrombotic conditions. Parenteral anticoagulants are particularly important in acute care situations given their fast onset of action. They are indicated for the management of acute coronary syndromes (ACS), in the treatment and prevention of venous thromboembolism (VTE), and in the management of heparin-induced thrombocytopenia (HIT). With the variety of oral anticoagulants now available, it is also important that pharmacists recognize the changing role of parenteral anticoagulants when the indications overlap with those of oral therapy. Furthermore, they must be able to safely transition patients from parenteral to oral anticoagulants.

This course is designed for pharmacists who are involved in decision making for parenteral anticoagulant selection or who provide care for patients who have already been prescribed a parenteral anticoagulant. The purpose of this course is to increase pharmacists’ knowledge of parenteral anticoagulants so that they can identify patients in whom therapy is indicated, assist in selecting the most appropriate option, and monitor and counsel the patient.

The focus of this course is on parenteral anticoagulants, their most pertinent prescribing information, and strategies for effective patient monitoring and counseling. This course begins with an overview of current practice guidelines for VTE prevention and treatment, HIT, and ACS. Then, an overview of the prescribing information for each associated parenteral anticoagulant follows, including strategies for reversal, patient monitoring, and counseling when applicable.

Universal Activity Number (UAN) - 0607-0000-16-008-H01-P

Type of Activity - Knowledge

Topic Designator - 01 – Disease State Management/Drug Therapy

This item contains 9 additional items. Click here to view the complete list